Estrogen-receptor-equipped mitochondria contribute to PAH by promoting nuclear respiratory factor-1 (NRF-1) transcription, which increases the amount of mitochondrial transcriptional factors (TFAM) (227). Here, NRF1 is linked to pulmonary arterial hypertension.